CN1580777A - 胶体金层析法检测血液hiv1/2抗体的试纸条及其制备方法 - Google Patents
胶体金层析法检测血液hiv1/2抗体的试纸条及其制备方法 Download PDFInfo
- Publication number
- CN1580777A CN1580777A CN 200410027292 CN200410027292A CN1580777A CN 1580777 A CN1580777 A CN 1580777A CN 200410027292 CN200410027292 CN 200410027292 CN 200410027292 A CN200410027292 A CN 200410027292A CN 1580777 A CN1580777 A CN 1580777A
- Authority
- CN
- China
- Prior art keywords
- antigen
- hiv1
- antibody
- preparation
- sample pad
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000012360 testing method Methods 0.000 title claims abstract description 53
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 title claims abstract description 46
- 210000004369 blood Anatomy 0.000 title claims abstract description 23
- 239000008280 blood Substances 0.000 title claims abstract description 23
- 238000004587 chromatography analysis Methods 0.000 title claims abstract description 15
- 238000000034 method Methods 0.000 title claims description 13
- 239000000427 antigen Substances 0.000 claims abstract description 64
- 108091007433 antigens Proteins 0.000 claims abstract description 63
- 102000036639 antigens Human genes 0.000 claims abstract description 63
- 241000713772 Human immunodeficiency virus 1 Species 0.000 claims abstract description 45
- 239000010931 gold Substances 0.000 claims abstract description 31
- 229910052737 gold Inorganic materials 0.000 claims abstract description 31
- 238000001514 detection method Methods 0.000 claims abstract description 24
- 239000003365 glass fiber Substances 0.000 claims abstract description 22
- 239000012528 membrane Substances 0.000 claims abstract description 19
- 101800001690 Transmembrane protein gp41 Proteins 0.000 claims abstract description 14
- 101710174880 Capsid vertex protein Proteins 0.000 claims abstract description 13
- 101800000385 Transmembrane protein Proteins 0.000 claims abstract description 10
- 238000011282 treatment Methods 0.000 claims abstract description 7
- 238000002360 preparation method Methods 0.000 claims description 39
- 239000000243 solution Substances 0.000 claims description 29
- 239000007788 liquid Substances 0.000 claims description 17
- 239000012530 fluid Substances 0.000 claims description 11
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 8
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 8
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 7
- 238000010790 dilution Methods 0.000 claims description 6
- 239000012895 dilution Substances 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 241000700605 Viruses Species 0.000 claims description 5
- 238000013016 damping Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 239000002244 precipitate Substances 0.000 claims description 5
- 239000004094 surface-active agent Substances 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 4
- 238000007639 printing Methods 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 239000007921 spray Substances 0.000 claims description 4
- 206010013786 Dry skin Diseases 0.000 claims description 3
- 239000011521 glass Substances 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 3
- 238000010353 genetic engineering Methods 0.000 claims description 2
- 238000010422 painting Methods 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- 208000030507 AIDS Diseases 0.000 abstract description 14
- 210000002966 serum Anatomy 0.000 abstract description 7
- 210000002381 plasma Anatomy 0.000 abstract description 5
- 241000725303 Human immunodeficiency virus Species 0.000 abstract description 4
- 239000011248 coating agent Substances 0.000 abstract 2
- 238000000576 coating method Methods 0.000 abstract 2
- 239000000523 sample Substances 0.000 description 34
- 239000012153 distilled water Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 238000005374 membrane filtration Methods 0.000 description 7
- 244000061458 Solanum melongena Species 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 239000001509 sodium citrate Substances 0.000 description 4
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 4
- 229940038773 trisodium citrate Drugs 0.000 description 4
- 238000002965 ELISA Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- FDWREHZXQUYJFJ-UHFFFAOYSA-M gold monochloride Chemical compound [Cl-].[Au+] FDWREHZXQUYJFJ-UHFFFAOYSA-M 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 235000020183 skimmed milk Nutrition 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- SJUCACGNNJFHLB-UHFFFAOYSA-N O=C1N[ClH](=O)NC2=C1NC(=O)N2 Chemical compound O=C1N[ClH](=O)NC2=C1NC(=O)N2 SJUCACGNNJFHLB-UHFFFAOYSA-N 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000003317 immunochromatography Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 230000005180 public health Effects 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- PXFBZOLANLWPMH-UHFFFAOYSA-N 16-Epiaffinine Natural products C1C(C2=CC=CC=C2N2)=C2C(=O)CC2C(=CC)CN(C)C1C2CO PXFBZOLANLWPMH-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- 229920002538 Polyethylene Glycol 20000 Polymers 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 239000005030 aluminium foil Substances 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 239000010836 blood and blood product Substances 0.000 description 1
- 229940125691 blood product Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000005138 cryopreservation Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229910021505 gold(III) hydroxide Inorganic materials 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 238000005325 percolation Methods 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200410027292 CN1254685C (zh) | 2004-05-21 | 2004-05-21 | 胶体金层析法检测血液hiv1/2抗体的试纸条及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200410027292 CN1254685C (zh) | 2004-05-21 | 2004-05-21 | 胶体金层析法检测血液hiv1/2抗体的试纸条及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1580777A true CN1580777A (zh) | 2005-02-16 |
CN1254685C CN1254685C (zh) | 2006-05-03 |
Family
ID=34582038
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200410027292 Expired - Lifetime CN1254685C (zh) | 2004-05-21 | 2004-05-21 | 胶体金层析法检测血液hiv1/2抗体的试纸条及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1254685C (zh) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101893629A (zh) * | 2010-07-13 | 2010-11-24 | 南京谦和有汇生物科技有限公司 | 一种torch筛查试纸条及其制备方法 |
CN102174109A (zh) * | 2011-01-21 | 2011-09-07 | 中华人民共和国吉林出入境检验检疫局 | 艾滋病病毒和梅毒螺旋体融合蛋白及制备方法和应用 |
CN102192979A (zh) * | 2010-03-08 | 2011-09-21 | 苏州浩欧博生物医药有限公司 | 非吸水性膜侧向层析一步分析法及其试剂盒 |
CN102197307A (zh) * | 2008-08-22 | 2011-09-21 | 电化生研株式会社 | 用于膜分析的配有参照显示部分的试验装置 |
CN102492041A (zh) * | 2011-11-29 | 2012-06-13 | 广州万孚生物技术有限公司 | Hiv重组融合抗原及其表达基因和制备方法 |
CN101556282B (zh) * | 2008-04-09 | 2012-12-26 | 河南农业大学 | 烟草复合病毒田间快速检测试纸条及其制备方法 |
CN101393213B (zh) * | 2007-09-20 | 2013-03-27 | 深圳市爱速尔生物技术有限公司 | Hiv-1/2抗体唾液检测仪 |
CN103376318A (zh) * | 2012-04-23 | 2013-10-30 | 齐明山 | 一种人类免疫缺陷病毒抗体确认试剂 |
CN103558381A (zh) * | 2013-11-06 | 2014-02-05 | 昆明云大生物技术有限公司 | 检测人类艾滋病病毒抗体的免疫层析试纸及其制备方法 |
CN106461651A (zh) * | 2014-06-04 | 2017-02-22 | 田中贵金属工业株式会社 | 免疫学的测定试剂的前带现象的消除法 |
CN111965175A (zh) * | 2020-08-12 | 2020-11-20 | 武汉普利赛斯科技有限公司 | 一种艾滋病血液检测试纸制备方法 |
CN113015905A (zh) * | 2018-11-19 | 2021-06-22 | 积水医疗株式会社 | 免疫层析测试条和免疫层析检测试剂盒 |
CN115541882A (zh) * | 2022-12-02 | 2022-12-30 | 南京申基医药科技有限公司 | 一种提高人类免疫缺陷病毒抗体检测试纸条的制备方法、试剂盒 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20140111192A (ko) * | 2013-03-08 | 2014-09-18 | (주)프로테옴텍 | 다중 진단용 병렬식 라인형 바이오칩 |
-
2004
- 2004-05-21 CN CN 200410027292 patent/CN1254685C/zh not_active Expired - Lifetime
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101393213B (zh) * | 2007-09-20 | 2013-03-27 | 深圳市爱速尔生物技术有限公司 | Hiv-1/2抗体唾液检测仪 |
CN101556282B (zh) * | 2008-04-09 | 2012-12-26 | 河南农业大学 | 烟草复合病毒田间快速检测试纸条及其制备方法 |
CN102197307A (zh) * | 2008-08-22 | 2011-09-21 | 电化生研株式会社 | 用于膜分析的配有参照显示部分的试验装置 |
CN102192979A (zh) * | 2010-03-08 | 2011-09-21 | 苏州浩欧博生物医药有限公司 | 非吸水性膜侧向层析一步分析法及其试剂盒 |
CN101893629A (zh) * | 2010-07-13 | 2010-11-24 | 南京谦和有汇生物科技有限公司 | 一种torch筛查试纸条及其制备方法 |
CN102174109A (zh) * | 2011-01-21 | 2011-09-07 | 中华人民共和国吉林出入境检验检疫局 | 艾滋病病毒和梅毒螺旋体融合蛋白及制备方法和应用 |
CN102492041A (zh) * | 2011-11-29 | 2012-06-13 | 广州万孚生物技术有限公司 | Hiv重组融合抗原及其表达基因和制备方法 |
CN102492041B (zh) * | 2011-11-29 | 2014-06-11 | 广州万孚生物技术股份有限公司 | Hiv重组融合抗原及其表达基因和制备方法 |
CN103376318A (zh) * | 2012-04-23 | 2013-10-30 | 齐明山 | 一种人类免疫缺陷病毒抗体确认试剂 |
CN103558381A (zh) * | 2013-11-06 | 2014-02-05 | 昆明云大生物技术有限公司 | 检测人类艾滋病病毒抗体的免疫层析试纸及其制备方法 |
CN106461651A (zh) * | 2014-06-04 | 2017-02-22 | 田中贵金属工业株式会社 | 免疫学的测定试剂的前带现象的消除法 |
US10466237B2 (en) | 2014-06-04 | 2019-11-05 | Tanaka Kikinzoku Kogyo K.K. | Method for excluding prozone phenomenon in immunological measurement reagent |
CN113015905A (zh) * | 2018-11-19 | 2021-06-22 | 积水医疗株式会社 | 免疫层析测试条和免疫层析检测试剂盒 |
CN111965175A (zh) * | 2020-08-12 | 2020-11-20 | 武汉普利赛斯科技有限公司 | 一种艾滋病血液检测试纸制备方法 |
CN115541882A (zh) * | 2022-12-02 | 2022-12-30 | 南京申基医药科技有限公司 | 一种提高人类免疫缺陷病毒抗体检测试纸条的制备方法、试剂盒 |
Also Published As
Publication number | Publication date |
---|---|
CN1254685C (zh) | 2006-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1254685C (zh) | 胶体金层析法检测血液hiv1/2抗体的试纸条及其制备方法 | |
EP1327885B1 (en) | A kit for the simultaneous diagnosis of a plurality of infectious diseases and a method for preparation of it | |
CN1168985C (zh) | 带有分离器的免疫色谱分析装置 | |
CN101650366B (zh) | 一种检测肠病毒的快速检测试纸及其制造方法 | |
CN104007261B (zh) | 禽三种呼吸道疾病三联快速检测试剂盒及应用 | |
CN2779402Y (zh) | 彩色多形式hcg测试试纸条 | |
CN101074956A (zh) | 一种检测嗜肺军团菌抗原的免疫层析试纸及其制备方法 | |
CN102109526B (zh) | 草鱼呼肠孤病毒快速检测试纸及其制备、使用方法 | |
CN1834652A (zh) | 一种检测布鲁氏菌的免疫层析试纸及其制备方法 | |
WO2006043614A1 (ja) | メンブランエンザイムイムノアッセイ法 | |
CN102887944A (zh) | 一种肺炎衣原体抗原,制备该抗原的方法,利用该抗原检测抗肺炎衣原体抗体的快速检测方法及试剂 | |
CN1144560A (zh) | 被分析物的检测方法 | |
CN105585633B (zh) | 抗人流感嗜血杆菌p6蛋白抗体及应用该抗体的免疫层析试剂盒 | |
CN101074955A (zh) | 一种检测嗜肺军团菌抗体的免疫层析试纸及其制备方法 | |
CN1122845C (zh) | 伤寒杆菌抗原多元检测测试条 | |
JP4365329B2 (ja) | 複数の被検出物を検出する簡易アッセイ装置及び方法 | |
JP3841559B2 (ja) | 免疫学的検査方法および免疫学的検査キット | |
WO2022024925A1 (ja) | シグナルの低下を改善した検査試薬 | |
CN101614736A (zh) | 应用新型全血样品垫处理方法的免疫层析检测试剂盒 | |
CN1254684C (zh) | 胶体金层析法检测双链dna抗体的试纸条及其制备方法 | |
CN105753982A (zh) | 抗人肺炎链球菌fam1家族PspA蛋白抗体及应用该抗体的免疫层析试剂盒 | |
CN109541206B (zh) | 一种布鲁氏菌抗体血清学鉴别诊断试纸 | |
CN102435744A (zh) | 弓形虫总抗体胶体金免疫层析检测试剂条及其制备方法 | |
CN112611863A (zh) | 一种用于检测2019新型冠状病毒的胶体碲试纸及制备方法 | |
CN101000346B (zh) | 一种检测炭疽芽孢杆菌的免疫层析试纸及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: GUANGZHOU WANFU BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: WANG JIHUA Effective date: 20110527 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 510640 WANFUYUAN, INSIDE SOUTH CHINA UNIVERSITY OF TECHNOLOGY, GUANGZHOU CITY, GUANGDONG PROVINCE TO: 510663 NO. 8, LIZHISHAN ROAD, SCIENCE CITY, LUOGANG DISTRICT, GUANGZHOU CITY, GUANGDONG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20110527 Address after: 510663 Guangzhou, Luogang District Science City, litchi Road, No. 8, No. Patentee after: GUANGZHOU WONDFO BIOTECH. Co.,Ltd. Address before: 510640 Guangdong city of Guangzhou Province on the campus of South China University of Technology Fuyuan million Patentee before: Wang Jihua |
|
C56 | Change in the name or address of the patentee |
Owner name: GUANGZHOU WONDFO BIOTECH. CO., LTD. Free format text: FORMER NAME: GUANGZHOU WANFU BIOTECHNOLOGY CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 510663 Guangzhou, Luogang District Science City, litchi Road, No. 8, No. Patentee after: GUANGZHOU WONDFO BIOTECH Co.,Ltd. Address before: 510663 Guangzhou, Luogang District Science City, litchi Road, No. 8, No. Patentee before: GUANGZHOU WONDFO BIOTECH. Co.,Ltd. |
|
CX01 | Expiry of patent term |
Granted publication date: 20060503 |
|
CX01 | Expiry of patent term |